Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017, Article ID 9031079, 11 pages
https://doi.org/10.1155/2017/9031079
Research Article

Leptin/Adiponectin Ratios Using Either Total Or High-Molecular-Weight Adiponectin as Biomarkers of Systemic Insulin Sensitivity in Normoglycemic Women

1Department of Nutrition, Diabetes and Metabolism, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
2Carrera de Nutrición y Dietética, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile
3School of Food Engineering, Universidad Austral de Chile, Valdivia, Chile

Correspondence should be addressed to José Luis Santos; lc.cup.dem@sotnasj

Received 7 December 2016; Accepted 13 March 2017; Published 25 May 2017

Academic Editor: Konstantinos Kantartzis

Copyright © 2017 Carolina Bravo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 32, Supplement 1, pp. S62–SS7, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. Organization WH, Prevention of Diabetes Mellitus: Report of a WHO Study Group [Meeting Held in Geneva from 16 to 20 November 1992], WHO Study Group, Switzerland, 1994. View at Publisher · View at Google Scholar
  3. T. Tamayo, R. Brinks, A. Hoyer, O. Kuß, and W. Rathmann, “The prevalence and incidence of diabetes in Germany: an analysis of statutory health insurance data on 65 million individuals from the years 2009 and 2010,” Deutsches Ärzteblatt International, vol. 113, no. 11, p. 177, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Watson, R. Wiers, B. Hommel, K. Ridderinkhof, and S. de Wit, “An associative account of how the obesogenic environment biases adolescents’ food choices,” Appetite, vol. 96, pp. 560–571, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Polonsky, B. Given, L. Hirsch et al., “Quantitative study of insulin secretion and clearance in normal and obese subjects,” Journal of Clinical Investigation, vol. 81, no. 2, p. 435, 1988. View at Publisher · View at Google Scholar
  6. E. A. Oral, V. Simha, E. Ruiz et al., “Leptin-replacement therapy for lipodystrophy,” New England Journal of Medicine, vol. 346, no. 8, pp. 570–578, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Elissondo, L. G. Rosso, P. Maidana, and F. Brites, “Adiponectina: una adipocitoquina con múltiples funciones protectoras,” Acta Bioquímica clínica Latinoamericana, vol. 42, no. 1, pp. 17–33, 2008, http://www.scielo.org.ar/scielo.phpscript=sci_arttext&pid=S0325-29572008000100004&lng=es&tlng=es. View at Google Scholar
  8. R. S. Lindsay, T. Funahashi, R. L. Hanson et al., “Adiponectin and development of type 2 diabetes in the Pima Indian population,” The Lancet, vol. 360, no. 9326, pp. 57-58, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Spranger, A. Kroke, M. Möhlig et al., “Adiponectin and protection against type 2 diabetes mellitus,” The Lancet, vol. 361, no. 9353, pp. 226–228, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Drapeau, É. Doucet, R. Rabasa-Lhoret, M. Brochu, D. Prud’homme, and P. Imbeault, “Improvement in insulin sensitivity by weight loss does not affect hyperinsulinemia-mediated reduction in total and high molecular weight a MONET study,” Applied Physiology, Nutrition, and Metabolism, vol. 36, no. 2, pp. 191–200, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Blüher, A. M. Brennan, T. Kelesidis et al., “Total and high–molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program comparative evaluation of three assays,” Diabetes Care, vol. 30, no. 2, pp. 280–285, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. W. F. Zeng, Y. Li, C. S. Sheng et al., “Association of anthropometric and bioelectrical impedance analysis measures of adiposity with high molecular weight adiponectin concentration,” PloS One, vol. 11, no. 5, article e0156041, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Hara, M. Horikoshi, T. Yamauchi et al., “Measurement of the high–molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome,” Diabetes Care, vol. 29, no. 6, pp. 1357–1362, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. F. M. Finucane, J. Luan, N. J. Wareham et al.D. B. Savage, “Correlation of the leptin: adiponectin ratio with measures of insulin resistance in non-diabetic individuals,” Diabetologia, vol. 52, no. 11, pp. 2345–2349, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Tura, S. Sbrignadello, E. Succurro, L. Groop, G. Sesti, and G. Pacini, “An empirical index of insulin sensitivity from short IVGTT: validation against the minimal model and glucose clamp indices in patients with different clinical characteristics,” Diabetologia, vol. 53, no. 1, pp. 144–152, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Inoue, M. Yano, M. Yamakado, E. Maehata, and S. Suzuki, “Relationship between the adiponectin-leptin ratio and parameters of insulin resistance in subjects without hyperglycemia,” Metabolism, vol. 55, no. 9, pp. 1248–1254, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. K. R. Segal, M. Landt, and S. Klein, “Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men,” Diabetes, vol. 45, no. 7, pp. 988–991, 1996. View at Publisher · View at Google Scholar
  18. W. T. Gibson, I. S. Farooqi, M. Moreau et al., “Congenital leptin deficiency due to homozygosity for the Δ133G mutation: report of another case and evaluation of response to four years of leptin therapy,” The Journal of Clinical Endocrinology & Metabolism, vol. 89, no. 10, pp. 4821–4826, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Xu and Q. Tong, “Central leptin action on euglycemia restoration in type 1 diabetes: restraining responses normally induced by fasting?” The International Journal of Biochemistry & Cell Biology, 2016, Epub ahead of print. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Liu, J. Lee, M. A. S. Hernandez, R. Mazitschek, and U. Ozcan, “Treatment of obesity with celastrol,” Cell, vol. 161, no. 5, pp. 999–1011, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Goldenberg, J. L. Santos, M. I. Hodgson, and V. A. Cortés, “Nuevas proyecciones fisiológicas, patológicas y terapéuticas de la leptina,” Revista médica de Chile, vol. 142, no. 6, pp. 738–747, 2014. View at Publisher · View at Google Scholar
  22. G. Paz-Filho, C. A. Mastronardi, and J. Licinio, “Leptin treatment: facts and expectations,” Metabolism, vol. 64, no. 1, pp. 146–156, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. S. S. Martin, A. Qasim, and M. P. Reilly, “Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease,” Journal of the American College of Cardiology, vol. 52, no. 15, pp. 1201–1210, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Araújo-Vilar, C. Guillín-Amarelle, S. Sánchez-Iglesias, A. Castro, and F. F. Casanueva, “Uso terapéutico de la leptina recombinante humana therapeutic use of recombinant leptin,” Revista Española de Endocrinologia Pediátrica, vol. 5, no. 1, pp. 27–42, 2014. View at Publisher · View at Google Scholar
  25. J. L. Santos, “Sistema leptina-melanocortinas en la regulación de la ingesta y el peso corporal,” Revista médica de Chile, vol. 137, no. 9, pp. 1225–1234, 2009. View at Publisher · View at Google Scholar
  26. S. Kaser, T. Tatarczyk, A. Stadlmayr et al., “Effect of obesity and insulin sensitivity on adiponectin isoform distribution,” European Journal of Clinical Investigation, vol. 38, no. 11, pp. 827–834, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. O. Tschritter, A. Fritsche, C. Thamer et al., “Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism,” Diabetes, vol. 52, no. 2, pp. 239–243, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Ruan and L. Q. Dong, “Adiponectin signaling and function in insulin target tissues,” Journal of Molecular Cell Biology, vol. 8, no. 2, pp. 101–109, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. C. N. A. Ayina, J. J. N. Noubiap, L. S. E. Ngoa et al., “Association of serum leptin and adiponectin with anthropomorphic indices of obesity, blood lipids and insulin resistance in a Sub-Saharan African population,” Lipids in Health and Disease, vol. 15, no. 1, p. 1, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. R. K. Semple, N. H. Halberg, K. Burling et al., “Paradoxical elevation of high–molecular weight adiponectin in acquired extreme insulin resistance due to insulin receptor antibodies,” Diabetes, vol. 56, no. 6, pp. 1712–1717, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Choi, J. Lee, K. Lee et al., “Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans,” Clinical Endocrinology, vol. 61, no. 1, pp. 75–80, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Seino, H. Hirose, I. Saito, and H. Itoh, “High-molecular-weight adiponectin is a predictor of progression to metabolic syndrome: a population-based 6-year follow-up study in Japanese men,” Metabolism, vol. 58, no. 3, pp. 355–360, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Lara-Castro, N. Luo, P. Wallace, R. L. Klein, and W. T. Garvey, “Adiponectin multimeric complexes and the metabolic syndrome trait cluster,” Diabetes, vol. 55, no. 1, pp. 249–259, 2006. View at Google Scholar
  34. U. B. Pajvani, M. Hawkins, T. P. Combs et al., “Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity,” Journal of Biological Chemistry, vol. 279, no. 13, pp. 12152–12162, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Tonelli, W. Li, P. Kishore et al., “Mechanisms of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes,” Diabetes, vol. 53, no. 6, pp. 1621–1629, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Wang, K. S. Lam, M. H. Yau, and A. Xu, “Post-translational modifications of adiponectin: mechanisms and functional implications,” Biochemical Journal, vol. 409, no. 3, pp. 623–633, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Nakashima, N. Kamei, K. Yamane, S. Nakanishi, A. Nakashima, and N. Kohno, “Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans,” The Journal of Clinical Endocrinology & Metabolism, vol. 91, no. 10, pp. 3873–3877, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Almeda-Valdes, D. Cuevas-Ramos, R. Mehta et al., “Total and high molecular weight adiponectin have similar utility for the identification of insulin resistance,” Cardiovascular Diabetology, vol. 9, no. 1, p. 1, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. D. L. Johannsen, Y. Tchoukalova, C. S. Tam et al., “Effect of 8 weeks of overfeeding on ectopic fat deposition and insulin sensitivity: testing the “adipose tissue expandability” hypothesis,” Diabetes Care, vol. 37, no. 10, pp. 2789–2797, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. R. N. Bergman, R. Prager, A. Volund, and J. Olefsky, “Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp,” Journal of Clinical Investigation, vol. 79, no. 3, p. 790, 1987. View at Publisher · View at Google Scholar
  41. U. Sánchez, G. Weisstaub, J. Santos, C. Corvalán, and R. Uauy, “GOCS cohort: children’s eating behavior scores and BMI,” European Journal of Clinical Nutrition, vol. 70, no. 8, pp. 925–928, 2016. View at Publisher · View at Google Scholar · View at Scopus
  42. L. Sánchez-Íñigo, D. Navarro-González, A. Fernández-Montero, J. Pastrana-Delgado, and J. A. Martínez, “The TyG index may predict the development of cardiovascular events,” European Journal of Clinical Investigation, vol. 46, no. 2, pp. 189–197, 2016. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Otten, B. Ahrén, and T. Olsson, “Surrogate measures of insulin sensitivity vs the hyperinsulinaemic–euglycaemic clamp: a meta-analysis,” Diabetologia, vol. 57, no. 9, pp. 1781–1788, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. L.-K. Er, S. Wu, H.-H. Chou et al., “Triglyceride glucose-body mass index is a simple and clinically useful surrogate marker for insulin resistance in nondiabetic individuals,” PloS One, vol. 11, no. 3, article e0149731, 2016. View at Publisher · View at Google Scholar · View at Scopus
  45. L. Menik and S. Palangasinghe, “Comparison of insulin resistance by indirect methods-HOMA, QUICKI and McAuley-with fasting insulin in patients with type 2 diabetes in Galle, Sri Lanka: a pilot study,” Online Journal of Health and Allied Science, vol. 5, no. 1, 2006, http://www.ojhas.org/issue17/2006-1-2.htm. View at Google Scholar